Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 0093-3421

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0093-3421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula (Cyclobenzaprine HCl Tablets A071611 1)

FDA Label Image

Label-5mg-100-tablets (Cyclobenzaprine HCl Tablets A071611 2)

Label-5mg-100-tablets (Cyclobenzaprine HCl Tablets A071611 2)
This text is describing a medication called Cyclobenzaprine Hydrochloride Tablets, USP. The medication comes in a bottle with an NDC code and a GIN code for identification. It is important to keep the medication out of reach of children and the adult dosage is provided. The tablet has the brand name "TaaPrums Fasbmn" and is manufactured by Teva. There are 100 tablets provided in the bottle, and there is a section for serialization coding.*
FDA Label Image

Label-7.5mg-100-tablets (Cyclobenzaprine HCl Tablets A071611 3)

FDA Label Image

Label-10mg-100-tablets (Cyclobenzaprine HCl Tablets A071611 4)

Label-10mg-100-tablets (Cyclobenzaprine HCl Tablets A071611 4)
This is a description of Cyclobenzaprine Hydrochloride Tablets, a prescription medication sold in bottles of 100. The National Drug Code (NDC) is 0093-3422-01, and the product is made by Teva. The text also contains a caution to keep the tablets out of reach of children, information about adult dosage and storage conditions, and a serial number for tracking purposes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.